Biomark Diagnostics Inc. (CSE:BUX)
Canada flag Canada · Delayed Price · Currency is CAD
0.475
-0.005 (-1.04%)
At close: Dec 5, 2025

Biomark Diagnostics Statistics

Total Valuation

CSE:BUX has a market cap or net worth of CAD 46.44 million. The enterprise value is 45.70 million.

Market Cap 46.44M
Enterprise Value 45.70M

Important Dates

The last earnings date was Thursday, November 27, 2025.

Earnings Date Nov 27, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 105.09M
Shares Outstanding n/a
Shares Change (YoY) +10.10%
Shares Change (QoQ) n/a
Owned by Insiders (%) 6.60%
Owned by Institutions (%) n/a
Float 53.56M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 376.27
PB Ratio 53.78
P/TBV Ratio 53.78
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -27.63
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -32.16

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.93.

Current Ratio 1.73
Quick Ratio 1.73
Debt / Equity 0.93
Debt / EBITDA n/a
Debt / FCF -0.56
Interest Coverage -42.29

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -79.14%
Return on Invested Capital (ROIC) -103.04%
Return on Capital Employed (ROCE) -197.52%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.09
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +115.91% in the last 52 weeks. The beta is -0.21, so CSE:BUX's price volatility has been lower than the market average.

Beta (5Y) -0.21
52-Week Price Change +115.91%
50-Day Moving Average 0.36
200-Day Moving Average 0.30
Relative Strength Index (RSI) 78.79
Average Volume (20 Days) 20,130

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, CSE:BUX had revenue of CAD 123,418 and -1.65 million in losses. Loss per share was -0.02.

Revenue 123,418
Gross Profit 123,418
Operating Income -1.74M
Pretax Income -1.65M
Net Income -1.65M
EBITDA -1.73M
EBIT -1.74M
Loss Per Share -0.02
Full Income Statement

Balance Sheet

The company has 1.55 million in cash and 799,168 in debt, giving a net cash position of 746,454.

Cash & Cash Equivalents 1.55M
Total Debt 799,168
Net Cash 746,454
Net Cash Per Share n/a
Equity (Book Value) 863,465
Book Value Per Share 0.01
Working Capital 727,713
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.41 million and capital expenditures -11,749, giving a free cash flow of -1.42 million.

Operating Cash Flow -1.41M
Capital Expenditures -11,749
Free Cash Flow -1.42M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -1,413.46%
Pretax Margin -1,340.24%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CSE:BUX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -10.10%
Shareholder Yield -10.10%
Earnings Yield -3.56%
FCF Yield -3.06%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CSE:BUX has an Altman Z-Score of -1.06 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.06
Piotroski F-Score 2